Seeking Alpha
 

Complete Genomics, Inc. (GNOM)

- NASDAQ
GNOM is defunct.
  • Nov. 26, 2012, 12:09 PM
    Ilumina (ILMN -3.6%) slips today on a Baird dowgrade to Neutral. Baird says there are near-term M&A risks, specifically citing ILMN's own bid for Complete Genomics (GNOM +0.2%) while chatter resurfaces about Roche (RHHBY.OB) potentially trying to buy ILMN again after falling to reach a deal earlier this year.
    | Nov. 26, 2012, 12:09 PM | Comment!
  • Nov. 21, 2012, 11:33 AM
    BGI-Shenzhen has again extended the deadline for its tender offer to acquire Complete Genomics (GNOM +1.6%), a move that comes in response to Illumina's (ILMN +0.8%) recently disclosed competing bid earlier this month that was rejected by the life sciences company. BGI's tender offer now expires on December 14.
    | Nov. 21, 2012, 11:33 AM | Comment!
  • Nov. 16, 2012, 5:40 PM
    After-hours top gainers, as of 5:15 p.m.: GNOM +12.5%. GTAT +5.1%. SWFT +4.6%. KFY +4.5%. STRI +4.5%
    After-hours top losers: KWK -10.4%. REGN -9.7%. BPZ -9.4%. FLO -9.2%. NSM -8.7%.
    | Nov. 16, 2012, 5:40 PM | Comment!
  • Nov. 13, 2012, 12:04 PM
    Shares of Complete Genomics (GNOM +3.3%) are up today on a report that it received an unsolicited $3.30 per share bid from "Party H" on November 5th. The offer follows an earlier tender offer from BGI-Shenzhen last month. Complete Genomics told Party H the bid didn't "constitute a superior proposal" and would likely not gain anti-trust clearance.
    | Nov. 13, 2012, 12:04 PM | Comment!
  • Sep. 17, 2012, 9:10 AM
    Premarket gainers: IRIS +45%. GNOM +15%. ODP +10%. KTOS +9%. CPRX +9%. TSLA +8%. DVAX +7%. CTIC +6%.
    Losers: THLD -23%.
    | Sep. 17, 2012, 9:10 AM | Comment!
  • Jul. 12, 2012, 9:10 AM
    Premarket gainers: GNOM +10%. VHC +7%.
    Losers: SVU -36%. INFY -10%. IMGN -6%. NMFC -5%. PGR -5%.
    | Jul. 12, 2012, 9:10 AM | Comment!
  • Jul. 12, 2012, 8:53 AM
    Complete Genomics (GNOM) +9.2% premarket and adding to a surge of 44% yesterday after it announced that its Long Fragment Read (LFR) technology, a new way of mapping DNA, "dramatically improves accuracy...and significantly reduces" the amount required for testing." That should make it more accessible to patients. (PR)
    | Jul. 12, 2012, 8:53 AM | Comment!
  • Jun. 5, 2012, 3:33 PM
    Complete Genomics' (GNOM +5.3%) restructuring and postponement of capacity expansion are incremental positives for Illumina (ILMN +1.1%), observes Leerink Swann. The firm says v pricing in the whole human genome sequencing market could stabilize as a result of GNOM' actions.
    | Jun. 5, 2012, 3:33 PM | Comment!
  • Jun. 5, 2012, 8:56 AM
    Complete Genomics (GNOM) +9.8% premarket after announcing it's laying off ~20% of its workforce to cut costs and has hired a financial adviser to help it explore strategic options including a possible sale of the company. GNOM says it is delaying expanding its monthly genome capacity until customer demand increases.
    | Jun. 5, 2012, 8:56 AM | Comment!
  • May 25, 2012, 9:05 AM
    Premarket gainers: GNOM +20%. FRO +7%.
    Losers: DCTH -36%. TLB -27%. GENE -11%. PAY -10%. NYMT -6%. VRML -6%.
    | May 25, 2012, 9:05 AM | Comment!
  • May 8, 2012, 3:57 PM
    Complete Genomics (GNOM -16%) drops hard after missing on its Q1 late yesterday on wider-than-expected losses. Revenue was down 42% Y/Y, largely due to an unexpected revenue recognition deferral for 200 units previously sold into Q2.
    | May 8, 2012, 3:57 PM | Comment!
  • Mar. 8, 2012, 9:00 AM
    Premarket gainers: MWA +18%. XOMA +8%. SQNM +7%. NBG +5%. GNOM +4%. CCI +4%. RAD +5%. MWW +4%. DB +4%. ING +4%. RIO +3%. MT +3%. BUD +3%. DRYS +3%. ARMH +3%. STO +3%. UBS +3%. SINA +3%. AEO +3%.
    Losers: DNDN -13%. STP -6%. ALKS -5%. WSM -4%. AMLN -4%. MCD -3%. CIGX -3%. UAL -3%. AGNC -3%.
    | Mar. 8, 2012, 9:00 AM | 2 Comments
  • Mar. 2, 2012, 2:48 PM
    This afternoon's spike in shares of Complete Genomics (GNOM +7.1%) may be attributable to remarks by CEO Cliff Reid on a recent paper that finds GNOM's whole genome sequencing service more accurate than Illumina's (ILMN +0.7%) HiSeq 2000 instrument. Reid says GNOM's sequencing produces 1/50th as many errors as ILMN's.
    | Mar. 2, 2012, 2:48 PM | Comment!
  • Feb. 15, 2012, 9:05 AM
    Premarket gainers: BPAX +51%. IPAS +21%. BCRX +14%. WCG +11%. TSEM +9%. CMCSK +8%. EGLE +7%. CLWR +7%. CMCSA +6%. ANF +6%. HIG +6%. VTG +5%. TTM +4%. K +3%. BCS +3%. DANG +3%. YGE +3%. DMND +3%. MET +3%. ACAS +3%. GNOM +3%. BZH +3%. COF +3%. TEVA +3%. MLU +3%.
    Losers: VG -12%. NBG -9%. RENN -8%. NZGA -6%. OC -5%. FXCM -3%. ALU -3%.
    | Feb. 15, 2012, 9:05 AM | Comment!
  • Feb. 14, 2012, 9:15 AM
    Complete Genomics (GNOM) tacks on another 2.2% gain premarket after surging yesterday on news that the Mayo Clinic will outsource whole human genome sequencing to the company. Shares are now up 59% YTD, but still trade at only a third of their 52-week highs.
    | Feb. 14, 2012, 9:15 AM | Comment!
  • Feb. 13, 2012, 11:35 AM
    Complete Genomics (GNOM) soars, now up over 50%, after saying it's has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing.
    | Feb. 13, 2012, 11:35 AM | Comment!
Visit Seeking Alpha's
Company Description
Currently, there's no company description for GNOM.
Sector: Healthcare
Industry: Biotechnology
Country: United States